• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

程序性死亡配体1(PD-L1)在肝细胞中由病毒感染以及α和γ干扰素诱导产生,并介导T细胞凋亡。

PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis.

作者信息

Mühlbauer Marcus, Fleck Martin, Schütz Christian, Weiss Thomas, Froh Matthias, Blank Christian, Schölmerich Jürgen, Hellerbrand Claus

机构信息

Department of Internal Medicine I, University of Regensburg, D-93042 Regensburg, Germany.

出版信息

J Hepatol. 2006 Oct;45(4):520-8. doi: 10.1016/j.jhep.2006.05.007. Epub 2006 Jun 16.

DOI:10.1016/j.jhep.2006.05.007
PMID:16876901
Abstract

BACKGROUND/AIMS: B7-H1 (PD-L1) is a B7-family member that binds to programmed death-1 (PD-1). Recently, deficiency of PD-L1 has been demonstrated to result in accelerated hepatocyte damage in experimental autoimmune hepatitis, and PD-L1 was suggested to play a critical role in regulating T cell homeostasis. Absence of PD-1 enhanced proliferation of T cells in adenovirus-infected livers and resulted in a rapid clearance of the virus. Here, we aimed to get more insight into hepatic PD-L1 expression, regulation and function.

METHODS

PD-L1 expression was analyzed by quantitative PCR and FACS-analysis in primary human liver cells and hepatoma cells. Furthermore, coculture experiments with primary human T cells or Jurkat T cells were established.

RESULTS

In addition to nonparenchymal liver cells, also hepatocytes constitutively expressed low levels of PD-L1. PD-L1 expression in hepatocytes was strongly enhanced by activated T cells and viral infection, and markedly augmented by further stimulation with type I or type II interferons. Moreover, PD-L1 expression on hepatocytes induced apoptosis in T cells.

CONCLUSIONS

Our results suggest a novel bidirectional interaction between hepatocytes and lymphocytes modulated by PD-L1 expression in hepatocytes, which may contribute to the unique immunological properties of the liver.

摘要

背景/目的:B7-H1(程序性死亡配体1,PD-L1)是一种B7家族成员,可与程序性死亡受体1(PD-1)结合。最近的研究表明,在实验性自身免疫性肝炎中,PD-L1缺乏会导致肝细胞损伤加速,提示PD-L1在调节T细胞稳态中起关键作用。在腺病毒感染的肝脏中,PD-1缺失会增强T细胞增殖,并导致病毒快速清除。在此,我们旨在更深入地了解肝脏中PD-L1的表达、调控及功能。

方法

采用定量PCR和流式细胞术分析原代人肝细胞和肝癌细胞中PD-L1的表达。此外,还建立了原代人T细胞或Jurkat T细胞的共培养实验。

结果

除了非实质肝细胞外,肝细胞也组成性表达低水平的PD-L1。活化的T细胞和病毒感染可显著增强肝细胞中PD-L1的表达,而Ⅰ型或Ⅱ型干扰素的进一步刺激则可使其明显上调。此外,肝细胞上的PD-L1表达可诱导T细胞凋亡。

结论

我们的结果提示,肝细胞与淋巴细胞之间存在一种由肝细胞中PD-L1表达调节的新型双向相互作用,这可能有助于肝脏独特的免疫特性。

相似文献

1
PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis.程序性死亡配体1(PD-L1)在肝细胞中由病毒感染以及α和γ干扰素诱导产生,并介导T细胞凋亡。
J Hepatol. 2006 Oct;45(4):520-8. doi: 10.1016/j.jhep.2006.05.007. Epub 2006 Jun 16.
2
Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism.表达程序性死亡配体1(PD-L1)的人角膜内皮细胞通过接触依赖性机制抑制PD-1 +辅助性T1细胞。
Invest Ophthalmol Vis Sci. 2009 Jan;50(1):263-72. doi: 10.1167/iovs.08-2536. Epub 2008 Sep 4.
3
PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesis.程序性死亡受体配体1(PD-L1)由人肾小管上皮细胞表达,并抑制T细胞细胞因子的合成。
Clin Immunol. 2005 May;115(2):184-91. doi: 10.1016/j.clim.2005.01.005.
4
Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease.共刺激分子程序性死亡-1及其配体在自身免疫性肝病中的肝内表达。
Pathol Int. 2007 Aug;57(8):485-92. doi: 10.1111/j.1440-1827.2007.02129.x.
5
Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens.PD-1 在识别磷酸抗原的人 γδ T 细胞中的表达和功能。
Eur J Immunol. 2011 Feb;41(2):345-55. doi: 10.1002/eji.201040959. Epub 2011 Jan 11.
6
Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.病毒特异性CD8 T细胞的动态程序性死亡1表达与急性乙型肝炎的转归相关。
Gastroenterology. 2008 Jun;134(7):1938-49, 1949.e1-3. doi: 10.1053/j.gastro.2008.03.037. Epub 2008 Mar 22.
7
Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice.肝星状细胞通过B7-H1介导的T细胞凋亡抑制小鼠T细胞反应。
Hepatology. 2004 Dec;40(6):1312-21. doi: 10.1002/hep.20488.
8
Expression of programmed death 1 and its ligands in the liver of autoimmune hepatitis C57BL/6 mice.程序性死亡 1 及其配体在自身免疫性肝炎 C57BL/6 小鼠肝脏中的表达。
Chin Med J (Engl). 2009 Aug 20;122(16):1941-6.
9
B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.肝细胞上的B7-H1促进特异性CD8 T细胞的致敏,但限制致敏反应的特异性回忆。
Gastroenterology. 2008 Sep;135(3):980-8. doi: 10.1053/j.gastro.2008.05.076. Epub 2008 Jun 4.
10
Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment.通过阻断PD-1/PD-L1恢复丙型肝炎病毒感染中丙型肝炎病毒特异性T细胞功能:病毒血症水平和抗病毒治疗的影响
J Hepatol. 2008 Apr;48(4):548-58. doi: 10.1016/j.jhep.2007.12.014. Epub 2008 Jan 28.

引用本文的文献

1
Targeting Hepatic Stellate Cell PD-L1 Alters Liver Inflammation and Fibrosis in CCl Liver Injury Mouse Model.靶向肝星状细胞程序性死亡受体配体1可改变四氯化碳诱导的肝损伤小鼠模型中的肝脏炎症和纤维化。
Cell Mol Gastroenterol Hepatol. 2025 Jul 16:101587. doi: 10.1016/j.jcmgh.2025.101587.
2
Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models.改善肝细胞癌免疫治疗:从患者和临床前模型中学习。
Gut Liver. 2025 Apr 3;2(1). doi: 10.1038/s44355-025-00018-y.
3
68Ga-NK224 PET/CT for Noninvasive Evaluation of PD-L1 Expression and Intertumor Heterogeneity: A Translational Exploratory Study.
68Ga-NK224 PET/CT用于PD-L1表达及肿瘤间异质性的无创评估:一项转化性探索性研究
Clin Cancer Res. 2025 Jul 15;31(14):2989-3001. doi: 10.1158/1078-0432.CCR-25-0160.
4
Current Treatment Regimens and Promising Molecular Therapies for Chronic Hepatobiliary Diseases.慢性肝胆疾病的当前治疗方案及有前景的分子疗法
Biomolecules. 2025 Jan 14;15(1):121. doi: 10.3390/biom15010121.
5
CMV IgG in the blood is not associated with hepatitis but correlates with poor outcomes in immunotherapy treated melanoma patients.血液中的巨细胞病毒IgG与肝炎无关,但与接受免疫治疗的黑色素瘤患者的不良预后相关。
Cancer Immunol Immunother. 2025 Jan 3;74(2):59. doi: 10.1007/s00262-024-03859-3.
6
Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy.PD-1/PD-L1信号轴在肿瘤发生中的作用及其被生物活性天然化合物靶向用于癌症免疫治疗的研究
Mil Med Res. 2024 Dec 18;11(1):82. doi: 10.1186/s40779-024-00586-9.
7
In situ editing of tumour cell membranes induces aggregation and capture of PD-L1 membrane proteins for enhanced cancer immunotherapy.原位编辑肿瘤细胞膜诱导 PD-L1 膜蛋白聚集和捕获,增强癌症免疫治疗。
Nat Commun. 2024 Nov 9;15(1):9723. doi: 10.1038/s41467-024-54081-9.
8
Expression of sPD-L1 levels in an ex vivo liver perfusion model.离体肝脏灌注模型中可溶性程序性死亡受体配体-1(sPD-L1)水平的表达
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae094.
9
Protective immune response induced by Leghorn male hepatoma cell-adapted fowl adenovirus-4.经来亨鸡雄性肝癌细胞适应的禽腺病毒4诱导的保护性免疫反应。
Heliyon. 2024 Feb 1;10(3):e25366. doi: 10.1016/j.heliyon.2024.e25366. eCollection 2024 Feb 15.
10
Targeting the immune microenvironment for ovarian cancer therapy.针对卵巢癌治疗的免疫微环境。
Front Immunol. 2023 Dec 18;14:1328651. doi: 10.3389/fimmu.2023.1328651. eCollection 2023.